Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
+1.89M
-
Total reported value, excl. options
-
$155M
-
Value change
-
+$21.8M
-
Put/Call ratio
-
3.3
-
Number of buys
-
54
-
Number of sells
-
-36
-
Price
-
$8.08
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q3 2024
121 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q3 2024.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 78.8M outstanding shares and own 24.29% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.66M shares), VANGUARD GROUP INC (3.07M shares), Elliott Investment Management L.P. (1.55M shares), Rosalind Advisors, Inc. (1.48M shares), GEODE CAPITAL MANAGEMENT, LLC (1.28M shares), STATE STREET CORP (1.23M shares), Voya Investment Management LLC (739K shares), NORTHERN TRUST CORP (447K shares), KENNEDY CAPITAL MANAGEMENT LLC (380K shares), and MORGAN STANLEY (342K shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.